LATHAM, N.Y. (AP) _ AngioDynamics Inc. (ANGO) on Thursday reported a loss of $8.5 million in its fiscal second quarter.

The Latham, New York-based company said it had a loss of 21 cents per share. Earnings, adjusted for one-time gains and costs, came to 1 cent per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.

The medical device maker posted revenue of $85.4 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $84 million.

AngioDynamics expects full-year earnings in the range of 1 cent to 6 cents per share, with revenue in the range of $342 million to $348 million.

AngioDynamics shares have declined 1% since the beginning of the year. The stock has dropped 53% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News